COVID-19 brought unprecedented public attention to the development, regulation, and timeline for products that prevent deadly infections, potentially heralding an era of vaccine innovation marked by ...

In Canada, switching to a one-dose, gender-neutral vaccination program for human papillomavirus (HPV) could use vaccine doses more efficiently and prevent a similar number of cervical cancer cases, ...

The US government has been the sole purchaser of COVID-19 vaccines since they were authorized for emergency use by the Food and Drug Administration. This was a major departure from the customary ...

First modelling study to quantify the impact of COVID-19 vaccines on a global scale estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first year after vaccines ...